BENSALEM, Pa.–(BUSINESS WIRE)–$HRTX #classaction–Law Offices of Howard G. Smith reminds investors of the upcoming August
5, 2019 deadline to file a lead plaintiff motion in the class
action filed on behalf of investors who purchased Heron Therapeutics,
Inc. (“Heron Therapeutics” or the “Company”) (NASDAQ: HRTX)
securities between October 31, 2018 and April 30, 2019, inclusive
(the “Class Period”).
Investors suffering losses on their Heron Therapeutics, Inc. investments
are encouraged to contact the Law Offices of Howard G. Smith to discuss
their legal rights in this class action at 888-638-4847 or by email to [email protected].
On May 1, 2019, the Company confirmed receipt of a Complete Response
Letter from the FDA in which the FDA was unable to approve the Company’s
New Drug Application for a new postoperative pain medication it had been
developing, due to the need for additional information.
On this news, shares of Heron Therapeutics fell $3.93 per share, or over
18%, to close at $17.75 on May 1, 2019, thereby injuring investors.
The complaint filed in this class action alleges that throughout the
Class Period, Defendants made materially false and/or misleading
statements, as well as failed to disclose material adverse facts about
the Company’s business, operations, and prospects. Specifically,
Defendants failed to disclose to investors: (1) the Company had failed
to include adequate Chemistry, Manufacturing, and Controls and
non-clinical information in its New Drug Application (“NDA”) with the
U.S. Food and Drug Administration (“FDA”) for HTX-011; (2) the foregoing
increased the likelihood that the FDA would not approve the Company’s
NDA for HTX-011; and (3) as a result, defendants’ public statements were
materially false and/or misleading at all relevant times.
If you purchased shares of Heron Therapeutics, Inc. during the Class
Period you may move the Court no later than August 5, 2019 to
ask the Court to appoint you as lead plaintiff if you meet certain legal
requirements. To be a member of the class action you need not take any
action at this time; you may retain counsel of your choice or take no
action and remain an absent member of the class action. If you wish
to learn more about this class action, or if you have any questions
concerning this announcement or your rights or interests with respect to
these matters, please contact Howard G. Smith, Esquire, of Law Offices
of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania
19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by
email to [email protected],
or visit our website at www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in some
jurisdictions under the applicable law and ethical rules.
Contacts
Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
888-638-4847
[email protected]
www.howardsmithlaw.com
